GlassScriptPhysician profile
Hans C Hansen
NPI 1750368197
$7,055.05
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,378 · 2020: $1,158 · 2021: $1,975 · 2022: $554 · 2023: $869 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $2,483.50 | 2019-2024 | Prolate, Nalocet |
| Collegium Pharmaceutical, INC. | $886.88 | 2019-2023 | Xtampza |
| Abbott Laboratories | $676.21 | 2019-2022 | |
| Boston Scientific Corporation | $399.69 | 2019-2022 | |
| Daiichi Sankyo INC. | $273.27 | 2019 | |
| Scilex Pharmaceuticals INC. | $253.89 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $230.33 | 2019-2021 | |
| Grt US Holding, INC. | $191.60 | 2021-2022 | |
| Pfizer INC. | $165.06 | 2019-2021 | |
| Medtronic, INC. | $162.37 | 2023 | Intellis Adaptivestim |
| Mdd US Operations, LLC | $156.79 | 2019-2020 | |
| Almatica Pharma LLC | $120.71 | 2021-2023 | Gralise, Sertraline Hcl, Loreev Xr |
| Indivior INC. | $119.45 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $105.76 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.51 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $84.64 | 2019 | |
| Nevro Corp. | $66.79 | 2019-2021 | |
| Nalu Medical, INC. | $63.88 | 2021 | |
| Orexo US, INC. | $61.43 | 2020-2022 | |
| Assertio Therapeutics, INC. | $54.11 | 2019 | |
| Zyla Life Sciences, INC. | $47.54 | 2019-2020 | |
| Virtus Pharmaceuticals LLC | $40.94 | 2021-2023 | Levorphanol Tartrate |
| Pernix Therapeutics Holdings, INC. | $39.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.17 | 2019-2020 | |
| Bioventus LLC | $23.92 | 2021 | |
| Redhill Biopharma INC. | $19.76 | 2021 | |
| Shionogi INC | $19.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.08 | 2019 | |
| Hikma Pharmaceuticals USA | $16.90 | 2021 | |
| Orthogenrx INC. | $15.82 | 2019 | |
| Medtronic USA, INC. | $15.00 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.93 | 2021 | |
| Currax Pharmaceuticals LLC | $14.44 | 2021 | |
| Uswm, LLC | $13.45 | 2021 | |
| Stimwave Technologies Incorporated | $12.43 | 2021 | |
| Amgen INC. | $12.22 | 2020 | |
| Sentynl Therapeutics, INC. | $11.82 | 2019 | |
| Lilly USA, LLC | $11.80 | 2021 | |
| Kaleo, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.